How the COVID-19 pandemic has changed the habits of sleep apnea patients and the level of use of CPAP therapy

Sleep apnea is a common sleep disorder, characterized by repeated interruptions of breathing during sleep. This condition disrupts the sleep cycle and can have significant effects on energy levels, mental performance and long-term health. In some cases, if left untreated, sleep apnea can be fatal.

Patients with sleep apnea had difficulty with CPAP therapy during COVID-19

Sleep apnea continues to have a significant impact on sleep quality worldwide, with the number of patients increasing slightly (2020: 9% compared to 2021: 12%). While Continuous Positive Airway Pressure (CPAP) therapy is the most common treatment prescribed for this condition, this year’s study shows a decrease in the percentage of sleep apnea patients using CPAP (2020: 36% vs. 2021: 18%) and an increase in the percentage of those who have never used CPAP (2020: 10% vs. 2021: 16%). With 72% of those discontinuing CPAP therapy citing COVID-19 reasons, such as financial challenges during this period (55%) and limited access to procurement of goods and services (44%), it appears that the COVID-19 pandemic was an inhibitory factor for CPAP therapy. One of the most worrying conclusions is that 57% of those living with sleep apnea have never received CPAP.

“Why are breathing disorders and sleep apnea important? Because they can be associated with decreased immunity, high blood pressure, obesity and even insulin resistance, and in children can negatively affect weight gain, heart activity or brain development. Snoring may signal sleep apnea. If we notice that a child or adult snores for more than a few weeks or months, it means that he is not breathing well during sleep. This can lead to low oxygen levels in the blood and high levels of carbon dioxide (CO2), as well as damage to the normal sleep pattern.

In both children and adults, changes during sleep can be observed and measured using different devices – pulse oximeter, polygraph, polysomnograph – depending on age, symptoms and availability of medical equipment, “said Dr. Mihaela Oros, president of the Association for Sleep Disorders in Children and Adolescents.

Anyone who thinks they are at risk for sleep apnea can visit site-ul Philips to take an online symptom test and to contact a healthcare professional. The latest findings from the global sleep quality study further strengthen the company’s commitment to developing clinically proven solutions that allow those living with sleep apnea and those with other sleep problems to regain control of their health. . For over 35 years, Philips has been studying sleep in a holistic way, collecting data from a large number of patients, data totaling millions of nights of sleep, to better understand how the nature of sleep affects health. Today, Philips’ portfolio of quality sleep solutions is growing and collectively addresses over 80% of known sleep problems. These solutions and services are supported by clinical research and technical data and provide personalized care to those who use them. COVID-19 has had a significant impact on the medical industry, and sleep care is no exception.

Remote monitoring devices have had a positive evolution. Since the beginning of 2020, for example, Philips has seen a 35% increase in the number of unique devices that have connected to its remote patient and sleep monitoring software, stressing the need for such of medical solutions.

.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.